Adiponectin receptor signalling in the brain

British Journal of Pharmacology

Volumn 165, Issue 2, 2012, Pages 313-327

  Thundyil, John ^a   Pavlovski, Dale ^a   Sobey, Christopher G ^b   Arumugam, Thiruma V ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

adiponectin; adiponectin receptors; Alzheimer's disease; brain diseases; cell death; ischaemic stroke; multiple sclerosis; neuronal cells; NF B

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR;

ALZHEIMER DISEASE; BRAIN; ENERGY EXPENDITURE; FOOD INTAKE; HORMONE ACTION; HUMAN; MILD COGNITIVE IMPAIRMENT; MULTIPLE SCLEROSIS; NEUROENDOCRINOLOGY; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SEIZURE; SIGNAL TRANSDUCTION; STROKE;

ADIPONECTIN; ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; RECEPTORS, ADIPONECTIN; SIGNAL TRANSDUCTION;

EID: 83755205446     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01560.x     Document Type: Review

References (185)

1. Ahima RS, Qi Y, Singhal NS, Jackson MB, Scherer PE, (2006). Brain adipocytokine action and metabolic regulation. Diabetes 55 (Suppl. 2): S145-S154. (Pubitemid 44927045)
2. Akifusa S, Kamio N, Shimazaki Y, Yamaguchi N, Yamashita Y, (2008). Regulation of globular adiponectin-induced apoptosis by reactive oxygen/nitrogen species in RAW264 macrophages. Free Radic Biol Med 45: 1326-1339.
3. Alberti L, Gilardini L, Girola A, Moro M, Cavagnini F, Invitti C, (2007). Adiponectin receptors gene expression in lymphocytes of obese and anorexic patients. Diabetes Obes Metab 9: 344-349. (Pubitemid 46502053)
4. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al,. (1999). Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83. (Pubitemid 29299050)
5. Aroda V, Ciaraldi TP, Chang SA, Dahan MH, Chang RJ, Henry RR, (2008). Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin action. Fertil Steril 89: 1200-1208. (Pubitemid 351671715)
6. Arumugam TV, Granger DN, Mattson MP, (2005). Stroke and T-cells. Neuromolecular Med 7: 229-242. (Pubitemid 41507146)
7. Axelsson J, Heimburger O, Lindholm B, Stenvinkel P, (2005). Adipose tissue and its relation to inflammation: the role of adipokines. J Ren Nutr 15: 131-136. (Pubitemid 40093697)
8. Aziz NA, van der Marck MA, Pijl H, Olde Rikkert MG, Bloem BR, Roos RA, (2008). Weight loss in neurodegenerative disorders. J Neurol 255: 1872-1880.
9. Bastard JP, Feve B, Bruckert E, (2009). Adipose tissue: an endocrine gland and organ of immunity. Sang Thromb Vaiss 21: 343-346.
10. Begley DJ, (1994). Peptides and the blood-brain barrier: the status of our understanding. Ann NY Acad Sci 739: 89-100.
11. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE, (2001). The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7: 947-953. (Pubitemid 32756433)
12. Berg AH, Combs TP, Scherer PE, (2002). ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13: 84-89. (Pubitemid 36740452)
13. Berner HS, Lyngstadaas SP, Spahr A, Monjo M, Thommesen L, Drevon CA, et al,. (2004). Adiponectin and its receptors are expressed in bone-forming cells. Bone 35: 842-849. (Pubitemid 39349215)
14. Beylot M, Pinteur C, Peroni O, (2006). Expression of the adiponectin receptors AdipoR1 and AdipoR2 in lean rats and in obese Zucker rats. Metabolism 55: 396-401. (Pubitemid 43234395)
15. Bluher M, Fasshauer M, Kralisch S, Krohn K, Paschke R, (2005). Regulation of adiponectin receptor R1 and R2 gene expression in adipocytes of C57BL/6 mice. Biochem Biophys Res Commun 329: 1127-1132. (Pubitemid 40341391)
16. Bonnard C, Durand A, Vidal H, Rieusset J, (2008). Changes in adiponectin, its receptors and AMPK activity in tissues of diet-induced diabetic mice. Diabetes Metab 34: 52-61.
17. Bottner A, Kratzsch J, Muller G, Kapellen TM, Bluher S, Keller E, et al,. (2004). Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 89: 4053-4061. (Pubitemid 39071513)
18. Brakenhielm E, Veitonmaki N, Cao RH, Kihara S, Matsuzawa YJ, Zhivotovsky B, et al,. (2004). Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci USA 101: 2476-2481. (Pubitemid 38269336)
19. Brass A, Kadler KE, Thomas JT, Grant ME, Boothandford RP, (1992). The fibrillar collagens, collagen-Viii, collagen-X and the C1q complement proteins share a similar domain in their c-terminal noncollagenous regions. FEBS Lett 303: 126-128.
20. Brochu-Gaudreau K, Rehfeldt C, Blouin R, Bordignon V, Murphy BD, Palin MF, (2010). Adiponectin action from head to toe. Endocrine 37: 11-32.
21. Bullen JW Jr, Bluher S, Kelesidis T, Mantzoros CS, (2007). Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice. Am J Physiol Endocrinol Metab 292: E1079-E1086. (Pubitemid 46536507)
22. Caminos JE, Nogueiras R, Gallego R, Bravo S, Tovar S, Garcia-Caballero T, et al,. (2005). Expression and regulation of adiponectin and receptor in human and rat placenta. J Clin Endocrinol Metab 90: 4276-4286. (Pubitemid 41058209)
23. Chandrasekar B, Boylston WH, Venkatachalam K, Webster NJG, Prabhu SD, Valente AJ, (2008). Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated Protein Kinase (AMPK) activation and IKK/NF-kappa B/PTEN suppression. J Biol Chem 283: 24889-24898.
24. Chang SP, Chen YH, Chang WC, Liu IM, Cheng JT, (2006). Increase of adiponectin receptor gene expression by physical exercise in soleus muscle of obese Zucker rats. Eur J Appl Physiol 97: 189-195.
25. Charlton HK, Webster J, Kruger S, Simpson F, Richards AA, Whitehead JP, (2010). ERp46 binds to AdipoR1, but not AdipoR2, and modulates adiponectin signalling. Biochem Biophys Res Commun 392: 234-239.
26. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ, (2003). Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 278: 45021-45026. (Pubitemid 37377262)
27. Chen MP, Tsai JC, Chung FM, Yang SS, Hsing LL, Shin SJ, et al,. (2005). Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arterioscler Thromb Vasc Biol 25: 821-826. (Pubitemid 40463876)
28. Chen J, Tan B, Karteris E, Zervou S, Digby J, Hillhouse EW, et al,. (2006). Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia 49: 1292-1302.
29. Cheng KK, Lam KS, Wang Y, Huang Y, Carling D, Wu D, et al,. (2007). Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells. Diabetes 56: 1387-1394. (Pubitemid 46715600)
30. Chinetti G, Zawadski C, Fruchart JC, Staels B, (2004). Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR. Biochem Biophys Res Commun 314: 151-158. (Pubitemid 38058382)
31. Christiansen T, Paulsen SK, Bruun JM, Ploug T, Pedersen SB, Richelsen B, (2009). Diet-induced weight loss and exercise alone and in combination enhance the expression of adiponectin receptors in adipose tissue and skeletal muscle, but only diet-induced weight loss enhanced circulating adiponectin. J Clin Endocrinol Metab 95: 911-919.
32. Civitarese AE, Jenkinson CP, Richardson D, Bajaj M, Cusi K, Kashyap S, et al,. (2004). Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes. Diabetologia 47: 816-820. (Pubitemid 38756993)
33. Civitarese AE, Ukropcova B, Hulver M, Defronzo R, Mandarino L, Scherer P, et al,. (2005). Adiponectin receptors mediated regulation of mitochondrial bioenergetics in skeletal-muscle. Diabetes 54: A91-A91.
34. Civitarese AE, Ukropcova B, Carling S, Hulver M, DeFronzo RA, Mandarino L, et al,. (2006). Role of adiponectin in human skeletal muscle bioenergetics. Cell Metab 4: 75-87. (Pubitemid 43942255)
35. Combs TP, Berg AH, Rajala MW, Klebanov S, Iyengar P, Jimenez-Chillaron JC, et al,. (2003). Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 52: 268-276. (Pubitemid 36173178)
36. Cong L, Gasser J, Zhao J, Yang B, Li F, Zhao AZ, (2007). Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95-2. Endocr Relat Cancer 14: 713-720. (Pubitemid 350074060)
37. Coope A, Milanski M, Araujo EP, Tambascia M, Saad MJ, Geloneze B, et al,. (2008). AdipoR1 mediates the anorexigenic and insulin/leptin-like actions of adiponectin in the hypothalamus. FEBS Lett 582: 1471-1476.
38. Dai MH, Xia T, Zhang GD, Chen XD, Gan L, Feng SQ, et al,. (2006). Cloning, expression and chromosome localization of porcine adiponectin and adiponectin receptors genes. Domest Anim Endocrinol 30: 117-125. (Pubitemid 43077101)
39. Dalrymple MB, Pfleger KDG, Eidne KA, (2008). G protein-coupled receptor dimers: functional consequences, disease states and drug targets. Pulm Pharmacol Ther 118: 359-371.
40. D'Anna R, Baviera G, Corrado F, Giordano D, De Vivo A, Nicocia G, et al,. (2006). Adiponectin and insulin resistance in early- and late-onset pre-eclampsia. BJOG 113: 1264-1269. (Pubitemid 44581516)
41. Deepa SS, Dong LQ, (2009). APPL1: role in adiponectin signaling and beyond. Am J Physiol Endocrinol Metab 296: E22-E36.
42. Delaigle AM, Jonas JC, Bauche IB, Cornu O, Brichard SM, (2004). Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies. Endocrinology 145: 5589-5597. (Pubitemid 39564599)
43. Dieudonne MN, Bussiere M, Dos Santos E, Leneveu MC, Giudicelli Y, Pecquery R, (2006). Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun 345: 271-279.
44. Ding ST, Liu BH, Ko YH, (2004). Cloning and expression of porcine adiponectin and adiponectin receptor 1 and 2 genes in pigs. J Anim Sci 82: 3162-3174. (Pubitemid 39431705)
45. Ding GL, Qin QH, He N, Francis-David SC, Hou J, Liu J, et al,. (2007). Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferator-activated receptor gamma. J Mol Cell Cardiol 43: 73-84. (Pubitemid 46898422)
46. Ding QR, Wang ZZ, Chen Y, (2009). Endocytosis of adiponectin receptor 1 through a clathrin- and Rab5-dependent pathway. Cell Res 19: 317-327.
47. Dos Santos E, Benaitreau D, Dieudonne MN, Leneveu MC, Serazin V, Giudicelli Y, et al,. (2008). Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells. Oncol Rep 20: 971-977.
48. Escobar-Morreale HF, Villuendas G, Botella-Carretero JI, Alvarez-Blasco F, Sanchon R, Luque-Ramirez M, et al,. (2006). Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study. Hum Reprod 21: 2257-2265. (Pubitemid 44530598)
49. Fantuzzi G, (2005). Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115: 911-919.
50. Fantuzzi G, (2008). Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol 121: 326-330.
51. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R, (2002). Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 290: 1084-1089. (Pubitemid 34687474)
52. Fasshauer M, Klein J, Kralisch S, Klier M, Lossner U, Bluher M, et al,. (2004). Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes. FEBS Lett 558: 27-32. (Pubitemid 38167405)
53. Felder TK, Hahne P, Soyal SM, Miller K, Hoffinger H, Oberkofler H, et al,. (2010). Hepatic adiponectin receptors (ADIPOR) 1 and 2 mRNA and their relation to insulin resistance in obese humans. Int J Obes 34: 846-851.
54. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, et al,. (2001). Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 98: 2005-2010. (Pubitemid 32165613)
55. Fry M, Smith PM, Hoyda TD, Duncan M, Ahima RS, Sharkey KA, et al,. (2006). Area postrema neurons are modulated by the adipocyte hormone adiponectin. J Neurosci 26: 9695-9702. (Pubitemid 44427708)
56. Garaulet M, Hernandez-Morante JJ, de Heredia FP, Tebar FJ, (2007). Adiponectin, the controversial hormone. Public Health Nutr 10: 1145-1150. (Pubitemid 350085203)
57. Gesta S, Tseng YH, Kahn CR, (2008). Developmental origin of fat: tracking obesity to its source (vol 131, pg 242, 2007). Cell 135: 366-366.
58. Ghavami S, Hashemi M, Ande SR, Yeganeh B, Xiao W, Eshraghi M, et al,. (2009). Apoptosis and cancer: mutations within caspase genes. J Med Genet 46: 497-510.
59. Glintborg D, Frystyk J, Hojlund K, Andersen KK, Henriksen JE, Hermann AP, et al,. (2008). Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome. Clin Endocrinol (Oxf) 68: 165-174.
60. Gu WQ, Li XY, Liu CQ, Yang J, Ye L, Tang JF, et al,. (2006). Globular adiponectin augments from pancreatic islet beta cells at insulin secretion high glucose concentrations. Endocrine 30: 217-221. (Pubitemid 46340525)
61. Guerre-Millo M, (2008). Adiponectin: an update. Diabetes Metab 34: 12-18.
62. Guo Z, Wang JP, (2010). Blockade of spinal nerves attenuates myocardial apoptosis in acute myocardial ischaemia/infarction in rats. Eur J Anaesthesiol 27: 146-152.
63. Hada Y, Yamauchi T, Waki H, Tsuchida A, Hara K, Yago H, et al,. (2007). Selective purification and characterization of adiponectin multimer species from human plasma. Biochem Biophys Res Commun 356: 487-493. (Pubitemid 46454397)
64. Hanyaloglu AC, von Zastrow M, (2008). Regulation of GPCRs by Endocytic membrane trafficking and its potential implications. Annu Rev Pharmacol Toxicol 48: 537-568. (Pubitemid 351738163)
65. Hattori Y, Hattori S, Kasai K, (2006). Globular adiponectin activates nuclear Factor-kappa B in vascular endothelial cells, which in turn induces expression of proinflammatory and adhesion molecule genes. Diabetes Care 29: 139-141. (Pubitemid 44033447)
66. Hattori Y, Nakano Y, Hattori S, Tomizawa A, Inukai K, Kasai K, (2008). High molecular weight adiponectin activates AMPK and suppresses cytokine-induced NF-kappa B activation in vascular endothelial cells. FEBS Lett 582: 1719-1724.
67. Haugen F, Drevon CA, (2007). Activation of nuclear factor-kappaB by high molecular weight and globular adiponectin. Endocrinology 148: 5478-5486. (Pubitemid 350012628)
68. Haugen F, Ranheim T, Harsem NK, Lips E, Staff AC, Drevon CA, (2006). Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expression. Am J Physiol Endocrinol Metab 290: E326-E333.
69. Heiker JT, Wottawah CM, Juhl C, Kosel D, Morl K, Beck-Sickinger AG, (2009). Protein kinase CK2 interacts with adiponectin receptor 1 and participates in adiponectin signaling. Cell Signal 21: 936-942.
70. Hietaharju A, Kuusisto H, Nieminen R, Vuolteenaho K, Elovaara I, Moilanen E, (2010). Elevated cerebrospinal fluid adiponectin and adipsin levels in patients with multiple sclerosis: a Finnish co-twin study. Eur J Neurol 17: 332-334.
71. Hoyda TD, Fry M, Ahima RS, Ferguson AV, (2007). Adiponectin selectively inhibits oxytocin neurons of the paraventricular nucleus of the hypothalamus. J Physiol 585: 805-816. (Pubitemid 350278717)
72. Hu E, Liang P, Spiegelman BM, (1996). AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271: 10697-10703. (Pubitemid 26145805)
73. Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS, Lodish HF, (2004). T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci USA 101: 10308-10313. (Pubitemid 38924921)
74. Ishikawa M, Vowinkel T, Stokes KY, Arumugam TV, Yilmaz G, Nanda A, et al,. (2005). CD40/CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia/reperfusion. Circulation 111: 1690-1696. (Pubitemid 40525171)
75. Ishikawa M, Kitayama J, Yamauchi T, Kadowaki T, Maki T, Miyato H, et al,. (2007). Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2. Cancer Sci 98: 1120-1127. (Pubitemid 46865400)
76. Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsuzawa Y, Makishima M, et al,. (2003). Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52: 1655-1663. (Pubitemid 36792453)
77. Jeon BT, Shin HJ, Kim JB, Kim YK, Lee DH, Kim KH, et al,. (2009). Adiponectin protects hippocampal neurons against kainic acid-induced excitotoxicity. Brain Res Rev 61: 81-88.
78. Jonsson JR, Moschen AR, Hickman IJ, Richardson MM, Kaser S, Clouston AD, et al,. (2005). Adiponectin and its receptors in patients with chronic hepatitis C. J Hepatol 43: 929-936. (Pubitemid 41627976)
79. Kahn BB, Alquier T, Carling D, Hardie DG, (2005). AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1: 15-25. (Pubitemid 43960587)
80. Kanazawa I, Yamaguchi T, Yano S, Yamauchi M, Yamamoto M, Sugimoto T, (2007). Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biol 8: 1-12.
81. Kang JH, Lee YY, Yu BY, Yang BS, Cho KH, Yoon DK, et al,. (2005). Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Arch Pharm Res 28: 1263-1269.
82. Kang KH, Higashino A, Kim HS, Lee YT, Kageyama T, (2009). Molecular cloning, gene expression, and tissue distribution of adiponectin and its receptors in the Japanese monkey, Macaca fuscata. J Med Primatol 38: 77-85.
83. Kaser S, Moschen A, Cayon A, Kaser A, Crespo J, Pons-Romero F, et al,. (2005). Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut 54: 117-121. (Pubitemid 40007229)
84. Kawai K, Kageyama A, Tsumano T, Nishimoto S, Fukuda K, Yokoyama S, et al,. (2008). Effects of adiponectin on growth and differentiation of human keratinocytes-implication of impaired wound healing in diabetes. Biochem Biophys Res Commun 374: 269-273.
85. Kharroubi I, Rasschaert J, Eizirik DL, Cnop M, (2003). Expression of adiponectin receptors in pancreatic beta cells. Biochem Biophys Res Commun 312: 1118-1122. (Pubitemid 37490931)
86. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, et al,. (2004). Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 94: E27-E31.
87. Kockx MM, Herman AG, (2000). Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc Res 45: 736-746. (Pubitemid 30047141)
88. Kola B, Boscaro M, Rutter GA, Grossman AB, Korbonits M, (2006). Expanding role of AMPK in endocrinology. Trends Endocrinol Metab 17: 205-215. (Pubitemid 43974977)
89. Konturek PC, Burnat G, Rau T, Hahn EG, Konturek S, (2008). Effect of adiponectin and ghrelin on apoptosis of barrett adenocarcinoma cell line. Dig Dis Sci 53: 597-605. (Pubitemid 351317076)
90. Korner A, Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I, Wiliams CJ, Kaprara A, et al,. (2007). Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95-2 (vol 14, pg 713, 2007). Endocr Relat Cancer 14: 1127-1127.
91. Kos K, Harte AL, da Silva NF, Tonchev A, Chaldakov G, James S, et al,. (2007). Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus. J Clin Endocrinol Metab 92: 1129-1136. (Pubitemid 46465692)
92. Kosel D, Heiker JT, Juhl C, Wottawah CM, Bluher M, Morl K, et al,. (2010). Dimerization of adiponectin receptor 1 is inhibited by adiponectin. J Cell Sci 123: 1320-1328.
93. Kubota N, Yano W, Kubota T, Yamauchi T, Itoh S, Kumagai H, et al,. (2007). Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab 6: 55-68. (Pubitemid 47007437)
94. Kusminski CM, McTernan PG, Schraw T, Kos K, O'Hare JP, Ahima R, et al,. (2007). Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum. Diabetologia 50: 634-642. (Pubitemid 46215508)
95. Li P, Sun F, Cao HM, Ma QY, Pan CM, Ma JH, et al,. (2009). Expression of adiponectin receptors in mouse adrenal glands and the adrenocortical Y-1 cell line: adiponectin regulates steroidogenesis. Biochem Biophys Res Commun 390: 1208-1213.
96. Liao WQ, Yu CA, Wen JY, Jia W, Li G, Ke YA, et al,. (2010). Adiponectin induces interleukin-6 production and activates STAT3 in adult mouse cardiac fibroblasts. Circulation 122: E193-E193.
97. Lin LY, Lin CY, Su TC, Liau CS, (2004). Angiotensin II-induced apoptosis in human endothelial cells is inhibited by adiponectin through restoration of the association between endothelial nitric oxide synthase and heat shock protein 90. FEBS Lett 574: 106-110.
98. Liu BH, Wang PH, Wang YC, Cheng WM, Mersmann HJ, Ding ST, (2008a). Fasting regulates the expression of adiponectin receptors in young growing pigs. J Anim Sci 86: 3377-3384.
99. Liu BH, Wang YC, Wu SC, Mersmann HJ, Cheng WT, Ding ST, (2008b). Insulin regulates the expression of adiponectin and adiponectin receptors in porcine adipocytes. Domest Anim Endocrinol 34: 352-359. (Pubitemid 351601611)
100. Luchsinger JA, (2008). Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective. Eur J Pharmacol 585: 119-129.
101. Luchsinger JA, Gustafson DR, (2009a). Adiposity and Alzheimer's disease. Curr Opin Clin Nutr Metab Care 12: 15-21.
102. Luchsinger JA, Gustafson DR, (2009b). Adiposity, type 2 diabetes, and Alzheimer's disease. J Alzheimers Dis 16: 693-704.
103. Maddineni S, Metzger S, Ocon O, Hendricks G, Ramachandran R, (2005). Adiponectin gene is expressed in multiple tissues in the chicken: food deprivation influences adiponectin messenger ribonucleic acid expression. Endocrinology 146: 4250-4256. (Pubitemid 41324020)
104. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K, (1996). CDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (Adipose most abundant gene transcript 1). Biochem Biophys Res Commun 221: 286-289. (Pubitemid 26136463)
105. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, et al,. (2002). Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8: 731-737. (Pubitemid 34778727)
106. Malagon MM, Rodriguez-Pacheco F, Martinez-Fuentes AJ, Tovar S, Pinilla L, Tena-Sempere M, et al,. (2006). Regulation of pituitary cell function by the adipokine adiponectin. Front Neuroendocrinol 27: 35-35.
107. Mao X, Kikani CK, Riojas RA, Langlais P, Wang L, Ramos FJ, et al,. (2006). APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol 8: 516-523.
108. Masaki T, Chiba S, Tatsukawa H, Yasuda T, Noguchi H, Seike M, et al,. (2004). Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice. Hepatology 40: 177-184. (Pubitemid 38868936)
109. Matsuzawa Y, (2005). Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease. Atherosclerosis Suppl 6: 7-14.
110. Mendez-Sanchez N, Chavez-Tapia NC, Zamora-Valdes D, Uribe M, (2006). Adiponectin, structure, function and pathophysiological implications in non-alcoholic fatty liver disease. Mini Rev Med Chem 6: 651-656. (Pubitemid 43881115)
111. Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M, (1996). Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem 120: 803-812. (Pubitemid 26385421)
112. Narasimhan ML, Coca MA, Jin JB, Yamauchi T, Ito Y, Kadowaki T, et al,. (2005). Osmotin is a homolog of mammalian adiponectin and controls apoptosis in yeast through a homolog of mammalian adiponectin receptor (vol 17, pg 171, 2005). Mol Cell 17: 611-611.
113. Neumeier M, Weigert J, Schaffler A, Weiss T, Kirchner S, Laberer S, et al,. (2005). Regulation of adiponectin receptor 1 in human hepatocytes by agonists of nuclear receptors. Biochem Biophys Res Commun 334: 924-929. (Pubitemid 41033208)
114. Neumeier M, Weigert J, Buettner R, Wanninger J, Schaffler A, Muller AM, et al,. (2007). Detection of adiponectin in cerebrospinal fluid in humans. Am J Physiol Endocrinol Metab 293: E965-E969. (Pubitemid 47535827)
115. Nishimura M, Izumiya Y, Higuchi A, Shibata R, Qiu J, Kudo C, et al,. (2008). Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms. Circulation 117: 216-223.
116. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, et al,. (2002). Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51: 2734-2741. (Pubitemid 34970926)
117. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, et al,. (2002). Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106: 2767-2770. (Pubitemid 35396973)
118. Otero M, Lago R, Gomez R, Lago F, Dieguez C, Gomez-Reino JJ, et al,. (2006). Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 65: 1198-1201. (Pubitemid 44277396)
119. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al,. (1999). Novel modulator for endothelial adhesion molecules-Adipocyte-derived plasma protein adiponectin. Circulation 100: 2473-2476. (Pubitemid 30005109)
120. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, et al,. (2004). Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 279: 1304-1309. (Pubitemid 38082655)
121. Pajvani UB, Du XL, Combs TP, Berg AH, Rajala MW, Schulthess T, et al,. (2003). Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin-Implications for metabolic regulation and bioactivity. J Biol Chem 278: 9073-9085. (Pubitemid 36800387)
122. Palanivel R, Fang XP, Park M, Eguchi M, Pallan S, De Girolamo S, et al,. (2007). Globular and full-length forms of adiponectin mediate specific changes in glucose and fatty acid uptake and metabolism in cardiomyocytes. Cardiovasc Res 75: 148-157. (Pubitemid 46873521)
123. Pan WH, Tu H, Kastin AJ, (2006). Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin. Peptides 27: 911-916.
124. Patel JV, Abraheem A, Dotsenko O, Creamer J, Gunning M, Hughes EA, et al,. (2008). Circulating serum adiponectin levels in patients with coronary artery disease: relationship to atherosclerotic burden and cardiac function. J Int Med 264: 593-598.
125. Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, Machado De Oliveira R, et al,. (2004). Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429: 771-776. (Pubitemid 38833129)
126. Psilopanagioti A, Papadaki H, Kranioti EF, Alexandrides TK, Varakis JN, (2009). Expression of adiponectin and adiponectin receptors in human pituitary gland and brain. Neuroendocrinology 89: 38-47.
127. Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB, et al,. (2004). Adiponectin acts in the brain to decrease body weight. Nat Med 10: 524-529. (Pubitemid 38667912)
128. Qiao L, Shao J, (2006). SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein alpha transcriptional complex. J Biol Chem 281: 39915-39924. (Pubitemid 46041795)
129. Rakatzi I, Mueller H, Ritzeler O, Tennagels N, Eckel J, (2004). Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1. Diabetologia 47: 249-258. (Pubitemid 38315361)
130. Ranscht B, Dourszimmermann MT, (1991). T-cadherin, a novel cadherin cell-adhesion molecule in the nervous-system lacks the conserved cytoplasmic region. Neuron 7: 391-402.
131. Rasmussen MS, Lihn AS, Pedersen SB, Bruun JM, Rasmussen M, Richelsen B, (2006). Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots. Obesity 14: 28-35. (Pubitemid 46214772)
132. Redinger RN, (2009). Fat storage and the biology of energy expenditure. Transl Res 154: 52-60.
133. Repunte-Canonigo V, Berton F, Cottone P, Reifel-Miller A, Roberts AJ, Morales M, et al,. (2010). A potential role for adiponectin receptor 2 (AdipoR2) in the regulation of alcohol intake. Brain Res 1339: 11-17.
134. Richards AA, Stephens T, Charlton HK, Jones A, MacDonald GA, Prins JB, et al,. (2006). Adiponectin multimerization is dependent on conserved lysines in the collagenous domain: evidence for regulation of multimerization by alterations in posttranslational modifications. Mol Endocrinol 20: 1673-1687. (Pubitemid 43967574)
135. Rodriguez-Pacheco F, Martinez-Fuentes AJ, Tovar S, Pinilla L, Tena-Sempere M, Dieguez C, et al,. (2007). Regulation of pituitary cell function by adiponectin. Endocrinology 148: 401-410. (Pubitemid 46023452)
136. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF, (1995). A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270: 26746-26749.
137. Schulz C, Paulus K, Lehnert H, (2010). Adipocyte-brain: crosstalk. Results Probl Cell Differ 52: 189-201.
138. Senolt L, Pavelka K, Housa D, Haluzik M, (2006). Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis. Cytokine 35: 247-252. (Pubitemid 44827741)
139. Shapiro L, Scherer PE, (1998). The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol 8: 335-338. (Pubitemid 28159119)
140. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, et al,. (2005). Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2 dependent mechanisms. Nat Med 11: 1096-1103. (Pubitemid 41486832)
141. Shibata R, Izumiya Y, Sato K, Papanicolaou K, Kihara S, Colucci WS, et al,. (2007). Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J Mol Cell Cardiol 42: 1065-1074. (Pubitemid 46829193)
142. Shimada K, Miyazaki T, Daida H, (2004). Adiponectin and atherosclerotic disease. Clin Chim Acta 344: 1-12. (Pubitemid 38626132)
143. Shimizu A, Takamura T, Matsuzawa N, Nakamura S, Nabemoto S, Takeshita Y, et al,. (2007). Regulation of adiponectin receptor expression in human liver and a hepatocyte cell line. Metabolism 56: 1478-1485. (Pubitemid 47562497)
144. Shklyaev S, Aslanidi G, Tennant M, Prima V, Kohlbrenner E, Kroutov V, et al,. (2003). Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats. Proc Natl Acad Sci USA 100: 14217-14222. (Pubitemid 37499217)
145. Shoji T, Shinohara K, Hatsuda S, Kimoto E, Fukumoto S, Emoto M, et al,. (2005). Altered relationship between body fat and plasma adiponectin in end-stage renal disease. Metabolism 54: 330-334. (Pubitemid 40250092)
146. Smith BW, Hebbard L, George J, (2009). Adiponectin induces pro-inflammatory cytokines in kupffer cells and tolerance to itself via the generation of IL-10. J Gastroenterol Hepatol 24: A274-A274.
147. Snehalatha C, Mukesh B, Simon M, Viswanathan V, Haffner SM, Ramachandran A, (2003). Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 26: 3226-3229. (Pubitemid 37466879)
148. Soderberg S, Stegmayr B, Stenlund H, Sjostrom LG, Agren A, Johansson L, et al,. (2004). Leptin, but not adiponectin, predicts stroke in males. J Int Med 256: 128-136. (Pubitemid 38998259)
149. Spranger J, Verma S, Gohring I, Bobbert T, Seifert J, Sindler AL, et al,. (2006). Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 55: 141-147. (Pubitemid 43343309)
150. Staiger H, Kaltenbach S, Staiger K, Stefan N, Fritsche A, Guirguis A, et al,. (2004). Expression of adiponectin receptor mRNA in human skeletal muscle cells is related to in vivo parameters of glucose and lipid metabolism. Diabetes 53: 2195-2201. (Pubitemid 39145571)
151. Staiger K, Stefan N, Staiger H, Brendel MD, Brandhorst D, Bretzel RG, et al,. (2005). Adiponectin is functionally active in human islets but does not affect insulin secretory function or beta-cell lipoapoptosis. J Clin Endocrinol Metab 90: 6707-6713. (Pubitemid 41759336)
152. Takeuchi T, Adachi Y, Ohtsuki Y, Furihata M, (2007). Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease. Med Mol Morphol 40: 115-120. (Pubitemid 47415941)
153. Tang YT, Hu TH, Arterburn M, Boyle B, Bright JM, Emtage PC, et al,. (2005). PAQR proteins: a novel membrane receptor family defined by an ancient 7-transmembrane pass motif. J Mol Evol 61: 372-380. (Pubitemid 41355862)
154. Thundyil J, Tang SC, Okun E, Shah K, Karamyan VT, Li YI, et al,. (2010). Evidence that adiponectin receptor 1 activation exacerbates ischemic neuronal death. Exp Transl Stroke Med 2: 1-8.
155. Tomas E, Tsao TS, Saha AK, Murrey HE, Zhang Cc C, Itani SI, et al,. (2002). Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci USA 99: 16309-16313. (Pubitemid 35462791)
156. Tomizawa A, Hattori Y, Kasai K, Nakano Y, (2008). Adiponectin induces NF-kappa B activiation that leads to suppression of cytokine-induced NF-kappa B activation in vascular endothelial cells: globular adiponectin vs. high molecular weight adiponectin. Diab Vasc Dis Res 5: 123-127. (Pubitemid 351839284)
157. Toussirot E, Streit G, Wendling D, (2007). The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr Med Chem 14: 1095-1100. (Pubitemid 46672628)
158. Trayhurn P, Beattie JH, (2001). Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60: 329-339. (Pubitemid 32772448)
159. Trayhurn P, Wood IS, (2004). Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92: 347-355. (Pubitemid 40277057)
160. Tsao TS, Murrey HE, Hug C, Lee DH, Lodish HF, (2002). Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J Biol Chem 277: 29359-29362. (Pubitemid 41079218)
161. Tsao TS, Tomas E, Murrey HE, Hug C, Lee DH, Ruderman NB, et al,. (2003). Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity-Different oligomers activate different signal transduction pathways. J Biol Chem 278: 50810-50817. (Pubitemid 37548930)
162. Tsou PL, Jiang YD, Chang CC, Wei JN, Sung FC, Lin CC, et al,. (2004). Sex-related differences between adiponectin and insulin resistance in schoolchildren. Diabetes Care 27: 308-313.
163. Tsuchida A, Yamauchi T, Ito Y, Hada Y, Maki T, Takekawa S, et al,. (2004). Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 279: 30817-30822. (Pubitemid 38938015)
164. Une K, Takei YA, Tomita N, Asamura T, Ohrui T, Furukawa K, et al,. (2010). Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer's disease. Eur J Neurol 18: 1006-1009.
165. Vasseur F, (2006). Adiponectin and its receptors: partners contributing to the 'vicious circle' leading to the metabolic syndrome? Pharmacol Res 53: 478-481. (Pubitemid 43767553)
166. Vazquez-Vela MEF, Torres N, Tovar AR, (2008). White adipose tissue as endocrine organ and its role in obesity. Arch Med Res 39: 715-728.
167. Viollet B, Foretz M, Guigas B, Horman S, Dentin R, Bertrand L, et al,. (2006). Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. J Physiol 574: 41-53. (Pubitemid 43905795)
168. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, et al,. (2003). Impaired multimerization of human adiponectin mutants associated with diabetes. Diabetes 52: A1-A1.
169. Waki H, Yamauchi T, Kamon J, Kita S, Ito Y, Hada Y, et al,. (2005). Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology 146: 790-796. (Pubitemid 40129836)
170. Wang AYH, Hickman IJ, Richards AA, Whitehead JP, Prins JB, MacDonald GA, (2005a). High molecular weight adiponectin correlates with insulin sensitivity in patients with hepatitis C genotype 3, but not genotype 1 infection. Am J Gastroenterol 100: 2717-2723.
171. Wang Y, Lam KSL, Xu JY, Lu G, Xu LY, Cooper GJS, et al,. (2005b). Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 280: 18341-18347. (Pubitemid 41389081)
172. Wang Y, Lam KSL, Chan L, Chan KW, Lam JBB, Lam MC, et al,. (2006a). Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex. J Biol Chem 281: 16391-16400.
173. Wang Y, Lam JB, Lam KSL, Liu J, Lam MC, Hoo RLC, et al,. (2006b). Adiponectin modulates the glycogen synthase kinase-3 beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res 66: 11462-11470. (Pubitemid 46009979)
174. Wang Y, Lam KS, Yau MH, Xu A, (2008). Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem J 409: 623-633. (Pubitemid 351214189)
175. Weigert J, Neumeier M, Wanninger J, Wurm S, Kopp A, Schober F, et al,. (2008). Reduced response to adiponectin and lower abundance of adiponectin receptor proteins in type 2 diabetic monocytes. FEBS Lett 582: 1777-1782.
176. Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB, (2006). Adiponectin-a key adipokine in the metabolic syndrome. Diabetes Obes Metab 8: 264-280.
177. Wilkinson M, Brown R, Imran SA, Ur E, (2007). Adipokine gene expression in brain and pituitary gland. Neuroendocrinology 86: 191-209. (Pubitemid 350073607)
178. Wood IS, Trayhurn P, (2007). Adipokines and the signaling role of adipose tissue in inflammation and obesity. Future Lipidol 1: 81-89.
179. Xu YZ, Wang NF, Ling F, Li PZ, Gao Y, (2009). Receptor for activated C-kinase 1, a novel binding partner of adiponectin receptor 1. Biochem Biophys Res Commun 378: 95-98.
180. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al,. (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946. (Pubitemid 32756432)
181. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, et al,. (2002). Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295. (Pubitemid 35373562)
182. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, et al,. (2003). Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423: 762-769. (Pubitemid 36735700)
183. Yoda-Murakami M, Taniguchi M, Takahashi K, Kawamata S, Saito K, Choi-Miura NH, et al,. (2001). Change in expression of GBP28/adiponectin in carbon tetrachloride-administrated mouse liver. Biochem Biophys Res Commun 285: 372-377. (Pubitemid 32918080)
184. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, et al,. (2000). Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96: 1723-1732. (Pubitemid 30661055)
185. Zeng Q, Isobe K, Fu L, Ohkoshi N, Ohmori H, Takekoshi K, et al,. (2007). Effects of exercise on adiponectin and adiponectin receptor levels in rats. Life Sci 80: 454-459. (Pubitemid 46013909)